More funding for heart disease research crucial for health of patients and the economy
American Heart Association Scientific Statement
- By 2030, more than 40 percent of the U.S. population is projected to have heart failure or other forms of heart disease, with costs exceeding $1 trillion in healthcare expenditures and lost productivity.
- Funding biomedical research is essential to the country’s health, but government and private funding is not keeping pace with need.
Embargoed until 3 p.m. CT / 4 p.m. ET Monday, June 26, 2017
DALLAS, June 26, 2017 — Biomedical research on heart disease produces a significant return on investment for both health and the economy, but government and private funding is not keeping pace with need, according to a new scientific statement published in the American Heart Association journal Circulation Research.
“For the last decade, biological research has been under siege owing to tightening budgets at the taxpayer funded National Institutes of Health and private funders,” said Joseph A. Hill, M.D., Ph.D. chair of the writing committee of the new scientific statement.
“Many people question the value of scientific research funded with taxpayer dollars, yet this research is essential to both our nation’s health and to our economy,” said Hill, who is also the James T. Willerson, M.D., distinguished chair in cardiovascular diseases at the University of Texas Southwestern Medical Center and the editor-in-chief of the American Heart Association journal Circulation.
For example, Hill pointed to the Women’s Health Initiative (WHI), which is estimated to have contributed to approximately 200,000 fewer cases of breast cancer and cardiovascular disease since its results were published in 2003. The initiative was funded by the National Institutes of Health.
In addition to the considerable health benefits from the WHI, the economic return from the $260 million program is estimated to be $37 billion in healthcare costs and work productivity, yielding a return on investment of $142 saved for every dollar spent.
While advances in treatments for heart disease over the last 50 years have led to a 75 percent decrease in deaths from heart attacks and other cardiovascular conditions, many people who previously would have died from a heart attack now leave the hospital with a damaged heart. This scenario frequently leads to heart failure, a chronic, progressive condition in which the heart muscle is unable to pump enough blood to maintain its workload.
“Beyond many benefits to individual and societal health, investments in research yield substantial economic returns in terms of jobs and tax revenues, products in the marketplace and for export, and skills that promote economic growth in other areas, which together ultimately “pay back” the money spent,” said Hill.
By 2030, more than 40 percent of the U.S. population is projected to have heart failure or other forms of heart disease, with costs exceeding $1 trillion in healthcare expenditures and lost productivity.
Discoveries that result from biomedical research lead to new insights into the underpinnings of disease, which in turn leads to new drug targets and the development of better drugs and improved diagnostic strategies.
Although scientific advances have dramatically prolonged the lives of people with heart disease, it remains the number one killer of men and women around the world and likely will continue into the future, Hill said.
Co-authors are Christine Seidman, M.D., vice-chair; Reza Ardehali, M.D., Ph.D.; Kimberli Taylor Clarke, M.D.; Gregory J. del Zoppo, M.D.; Lee L. Eckhardt, M.D.; Kathy K. Griendling, Ph.D.; Peter Libby, M.D.; Dan M. Roden, M.D.; Hesham A. Sadek, M.D.; and Douglas E. Vaughan, M.D.
Author disclosures are on the manuscript.
- Heart illustration availble on the right column on the release link: http://newsroom.heart.org/news/more-funding-for-heart-disease-research-crucial-for-health-of-patients-and-the-economy?preview=30f81f120de9a44a04843ea22bf48124
- After June 26, view the manuscript online.
- What is Heart Failure?
- Follow AHA/ASA news on Twitter @HeartNews.
The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical and device manufacturers and health insurance providers are available at www.heart.org/corporatefunding.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries: (214) 706-1173
Darcy Spitz: (212) 878-5940; Darcy.Spitz@heart.org
For Public Inquiries: (800)-AHA-USA1 (242-8721)